A Rare Case of Adenocarcinoma of Ampulla of Vater – A Case Report

Catalin Stefan Ghenea *

Clinical Department of Gastroenterology, Bucharest Emergency Clinical Hospital, Romania.

Livia Marieta Negoita

Clinical Department of Gastroenterology, Bucharest Emergency Clinical Hospital, Romania.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Periampullary tumors account approximately 5% of all gastrointestinal cancers, and Vater’s papilla. Vater’s papilla tumors are the second most common entity of periampullary cancer.

Case Presentation: We present a 69-year-old female patient who presented to the emergency room with symptoms including:  jaundice, hyperchromic urine and involuntary weight loss, which she havd developed over the preceding three weeks ago. The results of her laboratory tests showed hyperbilirubinemia with predominance of conjugated bilirubin and she had ultrasound scan of her abdomen and pelvis which demonstrated features adjudged to be suggestive of periampullary mass associated with dilated pancreatico-biliary tree. No abdominopelvic lymphadenopathy, no free peritoneal fluid on computed tomography (CT) scan was demonstrated. She underwent Endoscopic Retrograde Cholangio-Pancreatography (ERCP) which revealed a papillary apparatus with a budding, vegetative tumor with infiltration into her duodenum. She underwent exploratory laparotomy and Whipple’s pancreaticoduodenectomy. Histopathology examination of the excised surgical specimen revealed Vater’s papilla adenocarcinoma. She would be undergoing regular follow-up assessments after she has been discharged from hospital to ascertain her progress following her pancreato-duodenectomy which we had regarded as her treatment of curative intent pursuant to our multi-disciplinary team approach to her treatment.

Conclusions: Surgical resection is the only curative treatment for ampullary carcinoma and the standard surgical approach is pancreaticoduodenectomy. In absence of lymph node metastasis and any organ metastasis, it would be envisaged that the patient would have a good five year survival pursuant to her surgery and she would have regular careful follow-up assessments with inclusion of clinical assessments, laboratory test assessments and radiology imaging assessments.

Keywords: Periampullary cancer, adenocarcinoma, ERCP, pancreaticoduodenectomy, whipple procedure


How to Cite

Ghenea , Catalin Stefan, and Livia Marieta Negoita. 2023. “A Rare Case of Adenocarcinoma of Ampulla of Vater – A Case Report”. Asian Journal of Research and Reports in Gastroenterology 6 (1):122-26. https://journalajrrga.com/index.php/AJRRGA/article/view/111.

Downloads

Download data is not yet available.

References

Manta R, Conigliaro R, Castellani D, Messerotti A, Bertani H, Sabatino G, et al. Linear endoscopic ultrasonography vs magnetic resonance imaging in ampullary tumors. World J Gastroenterol. 2010; 16(44).

Romiti A. Tumors of ampulla of Vater: A case series and review of chemotherapy options. World J Gastrointest Oncol. 2012; 4(3).

Hagleitner G, A. Fellner F. Ampullary region tumors: A case of an intra-ampullary papillary-tubular neoplasm (IAPN). Glob Imaging Insights. 2020;5(3).

CATTELL RB, PYRTEK LJ. Premalignant lesions of the ampulla of Vater. Surg Gynecol Obstet. 1950;90(1).

Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T. Tumor of the ampulla of Vater: Experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999;134(5).

Ahn DH, Bekaii-Saab T. Ampullary cancer: an overview. Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meet. 2014;112–5.

Poley JW, Campos S. Methods and outcome of the endoscopic treatment of ampullary tumors. Therapeutic Advances in Gastrointestinal Endoscopy. 2020;13.

Askew J, Connor S. Review of the investigation and surgical management of resectable ampullary adenocarcinoma. HPB. 2013:15,.

Karakatsanis A, Vezakis A, Fragulidis G, Staikou C, Carvounis EE, Polydorou A. Obstructive jaundice due to ampullary metastasis of renal cell carcinoma. World J Surg Oncol. 2013;11.

Choi SB, Kim WB, Song TJ, Suh SO, Kim YC, Choi SY. Surgical outcomes and prognostic factors for ampulla of vater cancer. Scand J Surg. 2011;100(2):92–8.

Ito K, Fujita N, Noda Y. Endoscopic diagnosis and treatment of ampullary neoplasm (WITH VIDEO), Digestive Endoscopy. 2011:23.

Xiong JJ, Nunes QM, Huang W, Pathak S, Wei AL, Tan CL, et al. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol. 2013; 19(46).

Adams DH. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Gut. 2007;47:773–790.

Mantas D, Charalampoudis P, Nikiteas N. FAP related periampullary adenocarcinoma. Int J Surg Case Rep. 2013;4(8).

Basar O, Brugge WR. Adenoma and Adenocarcinoma of the Ampulla of Vater. In: The Pancreas [Internet]. John Wiley & Sons, Ltd; 2018:1058–67. Available:https://onlinelibrary.wiley.com/doi/abs/10.1002/9781119188421.ch140

Blechacz B, Gores GJ. Chapter 69 - Tumors of the Bile Ducts, Gallbladder, and Ampulla. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (Ninth Edition) [Internet]. Ninth Edit. Philadelphia: W.B. Saunders; 2010: 1171-1184.e3. Available:https://www.sciencedirect.com/science/article/pii/B978141606189200069X

Pea A, Riva G, Bernasconi R, Sereni E, Lawlor RT, Scarpa A, et al. Ampulla of Vater carcinoma: Molecular landscape and clinical implications. Vol. 10, World Journal of Gastrointestinal Oncology. 2018;370–80.

Kau SY, Shyr YM, Su CH, Wu CW, Lui WY. Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. J Am Coll Surg. 1999;188(4): 420–5.

Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, et al. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: The Johns Hopkins Hospital - Mayo Clinic collaborative study. Radiat Oncol. 2011; 6(1).